These subtypes—Estrogen Receptor positive/negative (ER+/ER-), Progesterone Receptor positive/negative (PR+/PR-), Human Epidermal Growth Factor Receptor 2 positive/negative (HER2+/HER2-), and Triple-Negative (TN/non-TN)—play critical roles in cancer progression. Here, ESR1 is linked to cancer.